CBUS

Legislation on New Genomic Techniques: The EU is advancing legislation to regulate New Genomic Techniques (NGTs) like gene editing, categorizing certain products as 'conventional-like' and exempting them from GMO regulations, which aims to enhance sustainable agriculture and align EU policies with global trading partners.

Cibus' Role and Impact: Cibus, an agricultural technology company, supports this regulatory progress, highlighting its potential to foster innovation in plant traits that improve crop resilience and productivity, ultimately benefiting European farmers and facilitating international trade.

Cibus Financial Results Announcement: Cibus, Inc. will report its fourth quarter 2024 financial results on March 20, 2025, with a conference call scheduled for 4:30 p.m. ET to discuss the results and company updates.

Company Overview: Cibus specializes in gene editing technologies to develop plant traits for major crops, focusing on productivity and sustainability challenges faced by farmers, and has a pipeline of five key productivity traits.

Cibus' White Mold Resistance Trait: Cibus has reported promising results from initial bioassay data for its third mode of action against white mold (Sclerotinia) in canola, which is expected to enhance crop yields and reduce fungicide usage for farmers.

Gene Editing Technology: The company utilizes its Rapid Trait Development System™ (RTDS) to quickly develop and prototype resistance traits, aiming to improve Sclerotinia resistance not only in canola but potentially in other crops like soybean as well.

Correction on Rice Conversion Rates: Cibus, Inc. has corrected its previously reported gene editing conversion rates for rice, stating that the 10-25% rates have not been reconfirmed due to high variability in data from subsequent experiments.

Focus on Agricultural Technology: The company continues to advance its oligonucleotide directed mutagenesis technologies and emphasizes its commitment to developing productivity traits for major crops like rice and canola, despite facing various operational risks and uncertainties.

Analyst Upgrades and Downgrades: Several Wall Street analysts have adjusted their price targets and ratings for various companies, including Netflix (target raised to $1,175), 3M (target raised to $165), and Seagate Technology (target raised to $134), while Fluence Energy and Cibus saw downgrades in their targets.

Stock Performance: The article highlights the closing prices of affected stocks on Tuesday, with notable mentions such as Netflix at $869.68, 3M at $146.89, and Apple at $222.64, reflecting market reactions to the analysts' updates.

Cibus Secures Funding: Cibus, Inc. has entered into securities purchase agreements for the sale of 9,040,000 shares of Class A Common Stock at $2.50 per share, aiming to raise approximately $22.6 million to fund its agricultural biotechnology projects and working capital.

Gene Editing Innovations: The company focuses on developing gene-edited productivity traits for major crops, addressing challenges like diseases and pests, with ongoing commercial development in collaboration with leading seed companies.

Cibus' Gene Editing Advancements: Cibus has established production standards for its proprietary RTDS gene editing process, enabling the development of traits in crops like Rice and Canola within 12 months, significantly improving efficiency and predictability in plant breeding.

Soybean Platform Development: Although Cibus did not achieve a fully operational soybean platform by the end of 2024, it successfully edited a Soybean cell with genetic changes related to herbicide tolerance, indicating progress in expanding its soybean capabilities.

Cibus Collaboration for Rice Herbicide: Cibus, in partnership with Albaugh and RTDC, is advancing the commercialization of its Clethodim-tolerant HT-3 rice trait, aimed at providing U.S. rice farmers with effective weed management solutions.

Importance of Herbicide Tolerance: The HT-3 trait represents a significant breakthrough in herbicide resistance, expected to enhance crop yield and quality while addressing challenges posed by weed pressure in rice production.

Collaboration Announcement: Cibus and Biographica have partnered to utilize AI technology for identifying gene editing targets aimed at enhancing disease resistance in oilseed rape and Canola crops.

Impact on Agriculture: This collaboration seeks to accelerate the development of resilient crop varieties, contributing to sustainable agricultural practices and addressing challenges such as disease pressure, which significantly affect global farming productivity.

Cibus Advances Canola Trait Development: Cibus has successfully edited Canola for its 4th mode of action related to Sclerotinia resistance, building on previous field trial results that demonstrated enhanced disease resistance. Greenhouse results are expected in early 2025.

Importance of Multiple Modes of Action: The company emphasizes the necessity of developing multiple modes of action to ensure durable disease resistance in crops like Canola and Soybean, akin to antiviral strategies in pharmaceuticals, addressing significant agricultural challenges.

Real-time Intelligence: Benzinga Pro offers traders the fastest and most accurate stock market intelligence, helping them make informed decisions daily.

Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and alerts generated by Benzinga reporters.

Financial Performance: Cibus Inc reported a net loss of $201.5 million for Q3 2024, with cash reserves expected to last only until early 2025, while R&D and SG&A expenses decreased compared to the previous year.

Commercial Developments: The company has transitioned to a commercial gene editing business, achieving significant advancements in herbicide-resistant traits and establishing collaborations with major seed companies, although regulatory uncertainties may delay revenue generation.

Cibus' HT2 Canola Development: Cibus, Inc. has successfully achieved greenhouse results for its second-generation herbicide-tolerant (HT2) Canola, paving the way for larger field testing in 2025, which aims to provide farmers with improved weed management solutions against resistant weeds.

Advancements in Gene Editing: The company's Rapid Trait Development System™ allows for faster development of complex traits, and the HT2 trait is expected to enhance herbicide tolerance across multiple crops, addressing sustainability challenges in agriculture.

Upcoming Financial Results Announcement: Cibus, Inc. will report its third quarter 2024 financial results on November 7, 2024, followed by a conference call at 4:30 p.m. ET to discuss the results and company updates.

Company Overview: Cibus is an agricultural technology company that develops and licenses plant traits for seed companies, focusing on enhancing productivity and sustainability in major crops through proprietary gene editing technology.

Real-time Trading Intelligence: Benzinga Pro offers traders the fastest and most accurate stock market intelligence, helping them stay updated with real-time news alerts.

Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and insights generated by Benzinga reporters.

Company Restructuring: Cibus, Inc. is implementing a restructuring plan that includes a reduction in workforce to optimize its business and reduce costs by approximately $10 million annually, while focusing on advancing its herbicide-resistant traits and other agricultural technologies.

Future Outlook: The CEO emphasized the company's transition from R&D to commercial stage gene editing in agriculture, aiming for efficient product launches and continued development of its soybean platform, despite potential risks and uncertainties affecting future operations.

Cibus Recognition: Cibus, Inc. has been named a finalist for the Euroseeds2024 InnovActor Award and will showcase its innovative RTDS-based breeding technology at the Euroseeds2024 Congress in Copenhagen, Denmark, highlighting advancements in modern plant breeding and agricultural sustainability.

Technological Advancements: The company's Trait Machine process utilizes proprietary gene editing technologies to enhance crop traits efficiently, aiming to address significant agricultural challenges while ensuring that the resulting traits are indistinguishable from those developed through conventional methods.

Cibus Participation at UNGA: Cibus, Inc. will participate in a panel discussion on climate-resilient seeds at the Food+ Forum during the United Nations General Assembly, highlighting the role of gene editing technology in addressing agricultural challenges related to climate change.

Cibus Technology Overview: Cibus utilizes its proprietary Rapid Trait Development System (RTDS) and Trait Machine process to develop plant traits for major crops, focusing on enhancing productivity and sustainability while collaborating with seed companies to integrate these innovations into their breeding programs.

Analyst Ratings Overview: Four analysts have recently provided ratings for Cibus, showing a mix of bullish sentiments with an average 12-month price target of $22.00, reflecting a positive shift from previous estimates.

Financial Performance Highlights: Cibus has demonstrated significant revenue growth of 325.38% over the past three months, alongside strong profitability indicators such as a net margin and return on equity that exceed industry averages.

Fastest News Alerts: Benzinga Pro offers real-time intelligence and news alerts to help traders stay informed and make winning trades in the stock market.

Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.